Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lanthanum Carbonate in Pediatric CKD Hyperphosphatemia
NCT01696279Phase 2Completed
- Sponsor
- Takeda
- Start
- Feb 2013
- Primary completion
- Nov 2018
- Modality
- Small Molecules
- Countries
- 9
01
Overview
A Phase 2 trial of lanthanum carbonate in hyperphosphatemia, sponsored by Takeda. Started Feb 2013; status: completed.
02
Drugs
lanthanum carbonate
03
Conditions
hyperphosphatemia
Beyond the preview
Go deeper on NCT01696279.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01696279.